Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Lessem

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Lancet. Respiratory Medicine|April 11, 2014
The evolving role of advocacy in tuberculosisAndrea DeLuca, Erica Lessem, Donna Wegener, et al.
The Lancet. Infectious Diseases|March 28, 2013
Engaging communities in tuberculosis researchRenaud F Boulanger, Stephanie Seidel, Erica Lessem, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2015
Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectivesErica Lessem, Helen Cox, Colleen Daniels, et al.
Gates Open Research|April 16, 2020
Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriersDiane N Singhroy, Emily MacLean, Mikashmi Kohli, et al.
The Lancet. Infectious Diseases|May 11, 2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statementSharon Nachman, Amina Ahmed, Farhana Amanullah, et al.
Contemporary Clinical Trials|January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trialSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
The Lancet. Respiratory Medicine|March 28, 2017
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisKeertan Dheda, Tawanda Gumbo, Gary Maartens, et al.
Lancet (London, England)|September 16, 2023
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on TuberculosisMichael Reid, Yvan Jean Patrick Agbassi, Nimalan Arinaminpathy, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Lancet. Respiratory Medicine|April 11, 2014
The evolving role of advocacy in tuberculosisAndrea DeLuca, Erica Lessem, Donna Wegener, et al.
The Lancet. Infectious Diseases|March 28, 2013
Engaging communities in tuberculosis researchRenaud F Boulanger, Stephanie Seidel, Erica Lessem, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2015
Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectivesErica Lessem, Helen Cox, Colleen Daniels, et al.
Gates Open Research|April 16, 2020
Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriersDiane N Singhroy, Emily MacLean, Mikashmi Kohli, et al.
The Lancet. Infectious Diseases|May 11, 2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statementSharon Nachman, Amina Ahmed, Farhana Amanullah, et al.
Contemporary Clinical Trials|January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trialSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
The Lancet. Respiratory Medicine|March 28, 2017
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisKeertan Dheda, Tawanda Gumbo, Gary Maartens, et al.
Lancet (London, England)|September 16, 2023
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on TuberculosisMichael Reid, Yvan Jean Patrick Agbassi, Nimalan Arinaminpathy, et al.
Pageof 2